I could not agree more! Well done

First 36 Last

Share
Profile

Follow
thecore

3,645 Posts.

283

04/07/24

12:41

Post #: 74605850
Share

Originally posted by Stockholm: ↑

I am the most genuine poster on here. I hold no malice to shareholders or even the company.

I will however call BS where I see it.

my concerns right now

1. expenses. Period.

2. use of funds from raise - let’s be honest, so far the past 5 or 10 have been pissed up against the wall and used to pay salaries of directors, failed acquisitions and products that never made market or failed. Danodan, Gummies, tea, capsules etc..

3. Statements from the company that are grey at best.

eg. ‘Oversubscribed’ cap raise which when you dig into it is under subscribed.

the recent rhetoric of a ‘independent’ research report from East Coast when East coast has been provided funds by CCO to conduct the research.

Little white lies (in my opinion) which make me question has the leopard changed its spots. Little things bleed into big things like how grey are some statements about revenue etc..

I don’t have a restored level of confidence or trust let’s just put it that way.

4. I watch coles sales like a hawk week in week out. 100%, there was movement of product when first ranged and the following month. The past few weeks stock on shelf is stagnant. I’ve seen one shot sell this past week.

The product up until 2-3 weeks ago was on sale constantly. Now it’s not. Coincidentally in line with cut off of reporting of the quarter and cap raise.

have 50% off sales used to artificially increase revenue when required to make the numbers look better than they really are.

5. transparency. I believe stocking of inventory is lumpy and this lumpy ness will be used in favour of CCO to boost quarters and look better than they really are. We really need to see 3 or 4 quarters to see the true cost of sales and profitability.

6. Is the current CEO the right person to be leading a retail focused supply chain company? When AN came onboard the company was straight lace pharmaceutical focus which fit the role. The company has evolved. New skills are required to take CCO to next level in my opinion.

Expand

I could not agree more! Well done

CCO Price at posting: 1.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 36 more messages in this thread...

First 36 Last

Add CCO (ASX) to my watchlist

(20min delay)
Last 0.9¢		Change 0.000(0.00%)		Mkt cap ! $19.81M

Open	High	Low	Value	Volume
0.9¢	0.9¢	0.9¢	$14.61K	1.623M

Buyers (Bids)

No.	Vol.	Price($)
3	1455100	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	8146456	8

View Market Depth

No.	Vol.	Price($)
3	1455100	0.009
10	3631914	0.008
7	3942856	0.007
7	2097366	0.006
1	90000	0.005

Price($)	Vol.	No.
0.010	8146456	8
0.011	15286503	18
0.012	3550000	3
0.013	5526596	4
0.014	71500	1

Last trade - 12.47pm 04/10/2024 (20 minute delay)

CCO (ASX) Chart

I could not agree more! Well done

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I could not agree more! Well done

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News